Various therapeutic strategies aimed at blocking VEGF activity are being used to control tumor angiogenesis induced by VEGF
It is also a key factor in activating eosinophils
and breast myoepithelial cells
Interleukin-13 Accession P35225 Amino Acid Sequence Gly35-Asn146
Crit Rev Clin Lab Sci
Olig2 Recombinant Rabbit mAb (SDT-648-155) Size:25μl Various therapeutic strategies aimed atProduct Specification Host Rabbit Antigen Olig2 Synonyms Oligodendrocyte transcription factor 2, Class B basic helix loop helix protein 1, Class E basic helix loop helix protein 19, Protein kinase C binding protein 2, Protein kinase C binding protein RACK17, BHLHB1, BHLHE19, PRKCBP2, RACK17, Olig 2, Olig 2 Immunogen Synthetic Peptide Location Cytoplasm, Nucleus Accession Q13516 Clone Number SDT 648 155 Antibody Type Recombinant mAb Isotype IgG